EKR Therapeutics Expands Its Management Team in Support of Growth Momentum

Business Wire, June 4, 2007

Bill, who has been honored with several sales awards, is a graduate of Yale University where he received his B.A. degree in Political Science.

About EKR Therapeutics

Founded by experienced healthcare and business executives, EKR Therapeutics is a privately held specialty pharmaceutical company that has brought together a highly seasoned team of industry professionals committed to providing prescription products and therapeutic solutions to support and enhance the quality-of-life of cancer patients. As new and increasingly effective oncology therapies emerge, more patients survive cancer. The EKR management team recognizes that oncology supportive products are becoming increasingly critical in the overall care of cancer patients, because the side-effects of oncology treatments can be severe and debilitating. EKR is committed to addressing this largely unmet medical need by collaborating with the full scope of healthcare practitioners in helping patients adhere to primary treatments through the use of supportive care products. EKR intends to identify, acquire, market, distribute and eventually develop therapeutics for patients in need of supportive care products during cancer treatment. For additional information about EKR visit the Company's website at http://www.ekrtx.com. Full prescribing information for Gelclair may be obtained at http://www.gelclair.com